Malaysian Genomics to market 'GenomeCheck' testing services in SEA


KUALA LUMPUR: Malaysian Genomics Resources Centre Bhd has entered into a distribution agreement with South Korea's Dx&Vx Co Ltd in a collaboration to ensure the smooth market entry of GenomeCheck, the latter company's genome testing services, in Southeast Asia.

In a filing with Bursa Malaysia, MGRC said it will be responsible for transporting the collected specimens to the designated testing locations using appropriate methods.

It will also be responsible for the development and expansion of the market through vigorous promotional and sales activities.

DxVx, meanwhile, will commit to providing the necessary promotional and academic materials to support

MGRCT advertising and sales activities.

The agreement shall be valid from June 28, 2024, until June 27, 2025, which unless terminated by either party, will be automatically extended for another year.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
MGRC , genomics , Dx&Vx , GenomeCheck

Next In Business News

FBM KLCI rises for second straight day amid mixed regional performance
Singapore shares set for an eight-day rally; Asia FX muted
Norway wealth fund posts US$40bil first-quarter loss on tech weakness
IJM acquires 50% stake in JRL Group to boost UK presence
ZUS Coffee to add 200 Southeast Asia stores in Starbucks duel
‘Made in Malaysia’: Sellers bombarded with ways to evade tariffs
Retailers up effort to help out exporters
Chinese customers are rejecting new jets due to tariffs, Boeing confirms
Toyota's March overseas sales hit record peak as US buyers rush ahead of tariffs
Oil steadies after 2% drop on potential Opec+ output increase

Others Also Read